STOCK TITAN

[Form 4] Zoetis Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4

Zoetis (ZTS) Executive Vice President filed a Form 4 reporting an acquisition of phantom stock units under the Zoetis Supplemental Savings Plan on 10/10/2025. The filing shows the addition of 149.8609 phantom stock units at a derivative security price of $46.71, bringing total derivative holdings to 5,226.362 units, held directly.

These phantom stock units are settled in cash after separation from service, and their value tracks Zoetis common stock plus a small cash-equivalent component. Transfers among plan investment funds are permitted, subject to plan limits.

Zoetis (ZTS) Vicepresidente Esecutivo ha presentato un Modulo 4 riferendo un'acquisizione di unità azionarie fantasma nell'ambito del Zoetis Supplemental Savings Plan il 10/10/2025. La presentazione mostra l'aggiunta di 149.8609 unità azionarie fantasma a un prezzo di strumento derivato di $46.71, portando le partecipazioni derivati totali a 5,226.362 unità, detenute direttamente.

Queste unità azionarie fantasma sono liquidate in contanti dopo la separazione dal servizio, e il loro valore è legato alle azioni ordinarie Zoetis più una piccola componente in contanti equivalente. I trasferimenti tra i fondi di investimento del piano sono consentiti, soggetti ai limiti del piano.

Zoetis (ZTS) Vicepresidente Ejecutivo presentó un Formulario 4 reportando una adquisición de unidades de acciones fantasma bajo el Zoetis Supplemental Savings Plan el 10/10/2025. La presentación muestra la adición de 149.8609 unidades de acciones fantasma a un precio de valor de un valor derivado de $46.71, llevando las participaciones derivadas totales a 5,226.362 unidades, mantenidas directamente.

Estas unidades de acciones fantasma se liquidan en efectivo tras la separación del servicio, y su valor sigue las acciones comunes de Zoetis más un pequeño componente equivalente en efectivo. Se permiten transferencias entre fondos de inversión del plan, sujetas a los límites del plan.

Zoetis (ZTS)의 임원 부사장은 2025년 10월 10일 Zoetis 보충 저축 계획(Zoitis Supplemental Savings Plan) 아래의 팬텀 주식 단위 취득을 보고하는 Form 4를 제출했습니다. 제출 내용에는 149.8609 팬텀 주식 단위가 파생 증권 가격 $46.71으로 추가되었고, 총 파생 보유량은 5,226.362 단위로 직접 보유됩니다.

이 팬텀 주식 단위는 서비스로부터의 분리 후 현금으로 정산되며, 그 가치는 Zoetis 보통주와 소액의 현가성 구성 요소를 반영합니다. 계획 내 투자 펀드 간의 이전은 허용되지만, 계획의 한도에 따라 다릅니다.

Zoetis (ZTS) Vice-président exécutif a déposé un Formulaire 4 signalant une acquisition d’unités d’actions fantômes dans le cadre du Zoetis Supplemental Savings Plan le 10/10/2025. Le fichier montre l’ajout de 149.8609 unités d’actions fantômes à un prix d’instrument dérivé de $46.71, portant les avoirs dérivés totaux à 5,226.362 unités, détenues directement.

Ces unités d’actions fantômes sont réglées en espèces après la séparation du service, et leur valeur suit les actions ordinaires Zoetis plus une petite composante équivalente en espèces. Les transferts entre les fonds d’investissement du plan sont autorisés, sous réserve des limites du plan.

Zoetis (ZTS) Executive Vice President hat ein Formular 4 eingereicht, das einen Erwerb von Phantomaktieneinheiten im Rahmen des Zoetis Supplemental Savings Plan am 10.10.2025 meldet. Die Einreichung zeigt die Hinzufügung von 149.8609 Phantomaktieneinheiten zu einem Derivate-Wertpapierpreis von $46.71, wodurch die gesamten Derivatebeteiligungen auf 5,226.362 Einheiten steigen, direkt gehalten.

Diese Phantomaktieneinheiten werden nach der Trennung vom Dienst in bar abgewickelt, und ihr Wert folgt Zoetis Stammaktien zuzüglich einer kleinen Barwertkomponente. Übertragungen zwischen Planafondsinvestitionen sind zulässig, vorbehaltlich der Planbeschränkungen.

Zoetis (ZTS) قدم نائب رئيس تنفيذي في Zoetis نموذج 4 للإبلاغ عن اكتساب وحدات أسهم فانتوم ضمن Zoetis Supplemental Savings Plan في 10/10/2025. يظهر الإيداع إضافة 149.8609 وحدة فانتوم سهم عند سعر أداة مشتقة قدره $46.71، مما رفع إجمالي الحيازات المشتقة إلى 5,226.362 وحدة، محفوظة مباشرة.

هذه الوحدات الفانتوم تتم تسويتها نقداً بعد الانفصال عن الخدمة، وقيمتها تتبع أسهم Zoetis العادية بالإضافة إلى عنصر نقدي مكافئ صغير. النقل بين صناديق الاستثمار في الخطة مسموح به، رهناً بقيود الخطة.

Zoetis (ZTS) 执行副总裁于 2025 年 10 月 10 日提交 Form 4,报告在 Zoetis Supplemental Savings Plan 下获得幻影股票单位。该申报显示添加了 149.8609 枚幻影股票单位,其衍生证券价格为 $46.71,使总衍生品持有量增至 5,226.362 枚单位,直接持有。

这些幻影股票单位在与服务分离后以现金结算,其价值跟踪 Zoetis 普通股并包含一个小的现金等价成分。计划投资基金之间的转移是允许的,但须遵守计划规定。

Positive
  • None.
Negative
  • None.

Zoetis (ZTS) Vicepresidente Esecutivo ha presentato un Modulo 4 riferendo un'acquisizione di unità azionarie fantasma nell'ambito del Zoetis Supplemental Savings Plan il 10/10/2025. La presentazione mostra l'aggiunta di 149.8609 unità azionarie fantasma a un prezzo di strumento derivato di $46.71, portando le partecipazioni derivati totali a 5,226.362 unità, detenute direttamente.

Queste unità azionarie fantasma sono liquidate in contanti dopo la separazione dal servizio, e il loro valore è legato alle azioni ordinarie Zoetis più una piccola componente in contanti equivalente. I trasferimenti tra i fondi di investimento del piano sono consentiti, soggetti ai limiti del piano.

Zoetis (ZTS) Vicepresidente Ejecutivo presentó un Formulario 4 reportando una adquisición de unidades de acciones fantasma bajo el Zoetis Supplemental Savings Plan el 10/10/2025. La presentación muestra la adición de 149.8609 unidades de acciones fantasma a un precio de valor de un valor derivado de $46.71, llevando las participaciones derivadas totales a 5,226.362 unidades, mantenidas directamente.

Estas unidades de acciones fantasma se liquidan en efectivo tras la separación del servicio, y su valor sigue las acciones comunes de Zoetis más un pequeño componente equivalente en efectivo. Se permiten transferencias entre fondos de inversión del plan, sujetas a los límites del plan.

Zoetis (ZTS)의 임원 부사장은 2025년 10월 10일 Zoetis 보충 저축 계획(Zoitis Supplemental Savings Plan) 아래의 팬텀 주식 단위 취득을 보고하는 Form 4를 제출했습니다. 제출 내용에는 149.8609 팬텀 주식 단위가 파생 증권 가격 $46.71으로 추가되었고, 총 파생 보유량은 5,226.362 단위로 직접 보유됩니다.

이 팬텀 주식 단위는 서비스로부터의 분리 후 현금으로 정산되며, 그 가치는 Zoetis 보통주와 소액의 현가성 구성 요소를 반영합니다. 계획 내 투자 펀드 간의 이전은 허용되지만, 계획의 한도에 따라 다릅니다.

Zoetis (ZTS) Vice-président exécutif a déposé un Formulaire 4 signalant une acquisition d’unités d’actions fantômes dans le cadre du Zoetis Supplemental Savings Plan le 10/10/2025. Le fichier montre l’ajout de 149.8609 unités d’actions fantômes à un prix d’instrument dérivé de $46.71, portant les avoirs dérivés totaux à 5,226.362 unités, détenues directement.

Ces unités d’actions fantômes sont réglées en espèces après la séparation du service, et leur valeur suit les actions ordinaires Zoetis plus une petite composante équivalente en espèces. Les transferts entre les fonds d’investissement du plan sont autorisés, sous réserve des limites du plan.

Zoetis (ZTS) Executive Vice President hat ein Formular 4 eingereicht, das einen Erwerb von Phantomaktieneinheiten im Rahmen des Zoetis Supplemental Savings Plan am 10.10.2025 meldet. Die Einreichung zeigt die Hinzufügung von 149.8609 Phantomaktieneinheiten zu einem Derivate-Wertpapierpreis von $46.71, wodurch die gesamten Derivatebeteiligungen auf 5,226.362 Einheiten steigen, direkt gehalten.

Diese Phantomaktieneinheiten werden nach der Trennung vom Dienst in bar abgewickelt, und ihr Wert folgt Zoetis Stammaktien zuzüglich einer kleinen Barwertkomponente. Übertragungen zwischen Planafondsinvestitionen sind zulässig, vorbehaltlich der Planbeschränkungen.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Driscoll Rimma

(Last) (First) (Middle)
C/O ZOETIS INC.
10 SYLVAN WAY

(Street)
PARSIPPANY NJ 07054

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Zoetis Inc. [ ZTS ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Executive Vice President
3. Date of Earliest Transaction (Month/Day/Year)
10/10/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Phantom Stock Unit(1) (2) 10/10/2025 A 149.8609 (1) (1) Common Stock 49.6067 $46.71 5,226.362 D
Explanation of Responses:
1. These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.
2. Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments.
Remarks:
/s/ Brenda Santuccio, as Attorney-in-Fact 10/14/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Zoetis (ZTS) report in this Form 4?

An Executive Vice President acquired 149.8609 phantom stock units under the Zoetis Supplemental Savings Plan on 10/10/2025.

How many derivative securities does the insider hold after the transaction?

Following the transaction, the insider beneficially owns 5,226.362 phantom stock units, held directly.

What was the price related to the phantom stock units?

The filing lists a $46.71 price for the derivative security.

How are these phantom stock units settled?

They are settled in cash after the reporting person’s separation from service.

What determines the value of each phantom stock unit?

Value is tied to the market value of Zoetis common stock plus a small cash-equivalent component (typically around 5% of total unit value).

Can the insider move these units among investment options?

Yes. Transfers to alternative investment funds are allowed, and Zoetis may limit timing and frequency.
Zoetis Inc

NYSE:ZTS

ZTS Rankings

ZTS Latest News

ZTS Latest SEC Filings

ZTS Stock Data

63.05B
442.76M
0.09%
98.66%
1.75%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States
PARSIPPANY